WellPoint raises 2014 earnings forecast

Back to TopCommentsE-mailPrintBookmark and Share

WellPoint is already raising a 2014 earnings forecast it laid out earlier this year, but the nation's second-largest health insurer's projections are still below analyst expectations.

The Blue Cross Blue Shield insurer, based in Indianapolis, says it now expects full-year earnings to be greater than $8.20 per share. WellPoint had said in late January that it expected earnings to be greater than $8 per share.

Analysts forecast earnings of $8.37 per share.

WellPoint is selling coverage on 14 state-based health insurance exchanges created through the federal health care overhaul, a law designed to help millions of uninsured people. Those exchanges started accepting enrollment for 2014 last fall, but many customers were left frustrated by technical glitches and frequent crashes, especially on the federal HealthCare.gov website, the main conduit for enrollment in many states.

Government officials have said the websites are running much better now.

WellPoint CEO Joseph Swedish said in a prepared statement Friday that the exchanges "are tracking our general expectations," and the company was encouraged so far by results across its business.

The exchanges make up a relatively small slice of WellPoint's overall business, which also includes employer-sponsored coverage and enrollment in the government's Medicare and Medicaid programs. The insurer said its total medical enrollment could grow 3 percent or 4 percent this year, to almost 37 million people. It trails only UnitedHealth Group Inc. in both revenue and enrollment.

WellPoint Inc. shares climbed 69 cents to top $100 in premarket trading and approach an all-time high price of $100.59 that the stock reached Wednesday.


Post a comment to this story

We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
You are legally responsible for what you post and your anonymity is not guaranteed.
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
Subscribe to IBJ